Wednesday, 27 August 2014

A Northern Territory-based research project investigating alternative and more practical treatments for skin sores (impetigo) is set to benefit the millions of children worldwide who suffer from this infection.

The Menzies School of Health Research (Menzies) paper, Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region, outlines the efficacy, feasibility and benefits of a new, non-injection treatment and has recently been published in the prestigious medical journal, The Lancet.

Read the full media release

View The Lancet article Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial, Dr Asha C Bowen FRACP, Steven Y C Tong PhD, Prof Ross M Andrews PhD, Irene M O'Meara RN, Malcolm I McDonald PhD, Mark D Chatfield MSc, Prof Bart J Currie FRACP, Prof Jonathan R Carapetis PhD, The Lancet, Early Online Publication, 27 August 2014